(Q46062593)
Statements
1 reference
Pharmacokinetic and pharmacodynamic profile of new biosimilar filgrastim XM02 equivalent to marketed filgrastim Neupogen: single-blind, randomized, crossover trial (English)
1 reference
Heinz Lubenau
1 reference
Peter Bias
1 reference
Anne-Katrin Maly
1 reference
Karl Ernst Siegler
1 reference
Kai Mehltretter
1 reference
1 January 2009
1 reference
1 reference
23
1 reference
1
1 reference
43-51
1 reference